Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.50 is 96% above its 5-year average of -12.52, near the high end of its 5-year range (-52.28–-0.50).
90.33% above its 12-month average of -5.17.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-06-30): -0.02.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 29 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:01:34.334Z. Historical observations retain their original dates. Historical series through 2016-03-31.
EARNINGS PER SHARE (EPS)
-0.50
EARNINGS PER SHARE (EPS) AVG TTM
-5.17
EARNINGS PER SHARE (EPS) AVG 3Y
-17.19
EARNINGS PER SHARE (EPS) AVG 5Y
-12.52
EARNINGS PER SHARE (EPS) AVG 10Y
-7.70
EARNINGS PER SHARE (EPS) AVG 15Y
-1.73
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+90.33%
CURRENT VS 3Y AVG
+97.09%
CURRENT VS 5Y AVG
+96.01%
CURRENT VS 10Y AVG
+93.51%
CURRENT VS 15Y AVG
+71.14%
CURRENT VS 20Y AVG
N/A
Canopy Growth Corporation
Market Cap
$373.40M
Earnings Per Share (EPS)
-0.50
TTM Avg
-5.17
3Y Avg
-17.19
5Y Avg
-12.52
Market Cap
$368.91M
Earnings Per Share (EPS)
-0.14
TTM Avg
-0.19
3Y Avg
-0.48
5Y Avg
-0.56
Market Cap
$366.39M
Earnings Per Share (EPS)
-2.41
TTM Avg
-4.66
3Y Avg
-5.40
5Y Avg
-4.56
Market Cap
$363.54M
Earnings Per Share (EPS)
2.65
TTM Avg
-5.30
3Y Avg
-10.00
5Y Avg
-10.52
Market Cap
$348.85M
Earnings Per Share (EPS)
1.48
TTM Avg
1.49
3Y Avg
2.03
5Y Avg
3.82
Market Cap
$348.59M
Earnings Per Share (EPS)
-3.31
TTM Avg
-3.43
3Y Avg
-2.65
5Y Avg
-2.61
Market Cap
$345.48M
Earnings Per Share (EPS)
-1.18
TTM Avg
-0.80
3Y Avg
-0.80
5Y Avg
-0.72
Market Cap
$406.47M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$339.15M
Earnings Per Share (EPS)
-1.58
TTM Avg
-1.99
3Y Avg
-1.86
5Y Avg
-1.78
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $373.40M | -0.50 | -5.17 | -17.19 | -12.52 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | -0.14 | -0.19 | -0.48 | -0.56 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $366.39M | -2.41 | -4.66 | -5.40 | -4.56 |
| Agenus Inc. (AGEN)vs › | $363.54M | 2.65 | -5.30 | -10.00 | -10.52 |
| Embecta Corp. (EMBC)vs › | $348.85M | 1.48 | 1.49 | 2.03 | 3.82 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | -3.31 | -3.43 | -2.65 | -2.61 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $345.48M | -1.18 | -0.80 | -0.80 | -0.72 |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | -1.71 | -1.36 | -1.12 | -1.12 |
| Cabaletta Bio, Inc. (CABA)vs › | $339.15M | -1.58 | -1.99 | -1.86 | -1.78 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | -4.63 | -6.16 | -6.16 | -6.16 |
Trailing EPS (TTM)
$-0.50
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-03-31 | -3.84 |
| 2024-03-31 | -6.50 |
| 2023-03-31 | -52.28 |
| 2022-03-31 | -6.15 |
| 2021-03-31 | -3.54 |
| 2020-03-31 | -2.81 |
| 2019-03-31 | -1.49 |
| 2018-03-31 | -0.24 |
| 2017-03-31 | -0.11 |
| 2016-03-31 | -0.03 |
| 2014-12-31 | -0.26 |
| 2013-12-31 | -0.87 |
| 2013-07-31 | -0.06 |
| 2012-07-31 | -0.02 |
| 2011-07-31 | -0.03 |
| 2010-07-31 | -0.03 |
